Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status

BACKGROUND: Expression of the oestrogen receptor (ER) in breast cancer predicts benefit from endocrine therapy. Minimising the frequency of false negative ER status classification is essential to identify all patients with ER positive breast cancers who should be offered endocrine therapies in order...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiyuan, Eklund, Aron C., Juul, Nicolai, Haibe-Kains, Benjamin, Workman, Christopher T., Richardson, Andrea L., Szallasi, Zoltan, Swanton, Charles
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995741/
https://www.ncbi.nlm.nih.gov/pubmed/21152022
http://dx.doi.org/10.1371/journal.pone.0015031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995741/
https://www.ncbi.nlm.nih.gov/pubmed/21152022
http://dx.doi.org/10.1371/journal.pone.0015031

Ejemplares similares